Triple

T22306630
Position Surface form Disambiguated ID Type / Status
Subject John C. Martin E551391 entity
Predicate memberOf P10 FINISHED
Object Gilead Sciences board of directors NE NERFINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Gilead Sciences board of directors | Statement: [John C. Martin, memberOf, Gilead Sciences board of directors]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Gilead Sciences board of directors
Context triple: [John C. Martin, memberOf, Gilead Sciences board of directors]
  • A. Gilead Sciences (board member) chosen
    Gilead Sciences is a major American biopharmaceutical company known for developing antiviral drugs, including treatments for HIV, hepatitis C, and other serious diseases.
  • B. BioMarin Pharmaceutical
    BioMarin Pharmaceutical is a biotechnology company specializing in developing and commercializing therapies for rare genetic diseases.
  • C. Ariad Pharmaceuticals
    Ariad Pharmaceuticals was a biotechnology company focused on developing targeted therapies for cancer and other serious diseases.
  • D. Regeneron Pharmaceuticals
    Regeneron Pharmaceuticals is a leading American biotechnology company known for developing innovative antibody-based therapies for serious diseases, including eye disorders, cancer, and inflammatory conditions.
  • E. Vertex Pharmaceuticals
    Vertex Pharmaceuticals is a biotechnology company best known for developing transformative therapies for cystic fibrosis and other serious diseases using a precision medicine approach.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e11e46c0188190800181a4233f28fe completed April 16, 2026, 5:37 p.m.
NER Named-entity recognition batch_69f157276d3c8190a55c93760a986cdc completed April 29, 2026, 12:56 a.m.
Created at: April 16, 2026, 8:41 p.m.